BCAX
Bicara Therapeutics Inc.
Bicara Therapeutics Inc. (BCAX) has 6 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 14, 2026.
The most active filer is Chief Financial Officer Hyep Ivan with 5 filings. Insiders have net sold $2.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Claire Mazumdar Clemon
- Employees:55
- HQ:Boston, MA, US
- IPO:2024-09-13
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.8M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$1.8B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Mazumdar ClaireFirst filing | Chief Executive Officer | Sale | 10,000 | $284K | Jul 14 | SEC ↗ |
| Chief Financial Officer | Sale | 28,000 | $808K | Jul 10 | SEC ↗ | |
Cohlhepp RyanFirst filing | President and COO | Sale | 28,214 | $818K | Jul 10 | SEC ↗ |
Cohlhepp RyanFirst filing | President and COO | Sale | 536 | $16K | Jul 10 | SEC ↗ |
Hyep IvanFirst in 8 months | Chief Financial Officer | Sale | 9,200 | $188K | May 26 | SEC ↗ |
Raben DavidFirst filing | Chief Medical Officer | Sale | 5,500 | $126K | Apr 28 | SEC ↗ |
Hyep IvanFirst filing | Chief Financial Officer | Sale | 6,514 | $118K | Oct 8 | SEC ↗ |
Hyep IvanFirst filing | Chief Financial Officer | Sale | 18,244 | $332K | Oct 8 | SEC ↗ |
Hyep IvanFirst filing | Chief Financial Officer | Sale | 5,627 | $102K | Oct 8 | SEC ↗ |
Related companies
Bicara Therapeutics Inc. is in the Healthcare sector.